Data generated by the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative phs000467 also found that TNFRSF4 was homogenously deleted in 5% of neuroblastoma cases. The gene discussed is TNFRSF4; the disease is neuroblastoma.